IRCT20210130050179N5招募中2 期
Clinical investigation of the safety and effectiveness of Topaz hair strengthening solution in preventing and improving male pattern androgenic hair loss
Qeshm Rojin Company0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •Male aged 18-50 years
- •General health
- •Hair Loss Status II, III, IV Based on Norwood Scale
- •Voluntary participation and signing written informed consent
排除标准
- •Chronic active scalp disease other than hair loss
- •Using any prescribed drug or OTC for hair loss within the past 3 months
- •Documented sensitivity to formulation components
- •Any severe weight loss or strict diet therapy during the study
研究者
相似试验
招募中
2 期
Clinical investigation of the safety and effectiveness of Excilia Hair strengthening and ani hair loss Lotion in improving hair lossHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20210130050179N6Zist orchid pharmed Company25
已完成
不适用
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastasesJPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
进行中（未招募）
1 期
Clinical study to evaluate the efficacity and safety of octagam®10% in idiopathic thrombocytopenic purpura in adults - N/AEUCTR2005-003552-35-FROctapharma AG116
已完成
不适用
Clinical study for the safety and effectiveness of the use of Perfectha® Derm lidocaine in the treatment of medium wrinklesISRCTN20356582Sinclair Pharma70
尚未招募
不适用
Clinical research of the effect and the safety with 0.1% bromfenac sodium hydrate ophthalmic solution and 0.1% betamethasone sodium phosphate ophthalmic, otic and nasal solution in patients with diabetic macular edemaJPRN-UMIN000026201Diabetes Center Tokyo Womens Medical University School of Medicine20